VDR and vitamin D deficiency: VDR expression is the main determinant of cell responsiveness to 1,25(OH)2D3 and is often downregulated in advanced CRC, which together with frequent vitamin D deficiency implies that these patients would probably not benefit from the anticancer effects of 1,25(OH)2D318-20.